Literature DB >> 24164159

Lower-dose thalidomide therapy effectively treats cutaneous lupus erythematosus but is limited by neuropathic toxicity.

Hillary C Frankel1, Victoria R Sharon, Ruth Ann Vleugels, Joseph F Merola, Abrar A Qureshi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24164159     DOI: 10.1111/j.1365-4632.2011.05200.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


× No keyword cloud information.
  6 in total

Review 1.  Therapeutic options for cutaneous lupus erythematosus: recent advances and future prospects.

Authors:  Joshua Chang; Victoria P Werth
Journal:  Expert Rev Clin Immunol       Date:  2016-06-01       Impact factor: 4.473

Review 2.  Cutaneous Lupus Erythematosus: Progress and Challenges.

Authors:  Amy J Petty; Lauren Floyd; Christopher Henderson; Matilda W Nicholas
Journal:  Curr Allergy Asthma Rep       Date:  2020-04-04       Impact factor: 4.806

3.  High-dose thalidomide increases the risk of peripheral neuropathy in the treatment of ankylosing spondylitis.

Authors:  Hong-Xia Xue; Wen-Yi Fu; Hua-Dong Cui; Li-Li Yang; Ning Zhang; Li-Juan Zhao
Journal:  Neural Regen Res       Date:  2015-05       Impact factor: 5.135

4.  Current Insights Into The Management Of Discoid Lupus Erythematosus.

Authors:  Jaime Company-Quiroga; Sergio Alique-García; Alberto Romero-Maté
Journal:  Clin Cosmet Investig Dermatol       Date:  2019-10-03

5.  Thalidomide and discoid lupus erythematosus: case series and review of literature.

Authors:  Giovanna Malara; Chiara Verduci; Maria Altomonte; Maria Cuzzola; Caterina Trifirò; Cristina Politi; Giovanni Tripepi
Journal:  Drugs Context       Date:  2022-03-16

Review 6.  An update on the management of refractory cutaneous lupus erythematosus.

Authors:  Alice Verdelli; Alberto Corrà; Elena Biancamaria Mariotti; Cristina Aimo; Valentina Ruffo di Calabria; Walter Volpi; Lavinia Quintarelli; Marzia Caproni
Journal:  Front Med (Lausanne)       Date:  2022-09-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.